ETFs QuidelOrtho Corporation

QDEL

US2197981051

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 12:49:33 2026-05-15 pm EDT			5-day change	1st Jan Change
11.06 ^USD	-2.94%		+2.04%	-61.41%

May. 07	UBS Adjusts Price Target on QuidelOrtho to $12 From $17, Maintains Neutral Rating	MT
May. 07	Jefferies Downgrades QuidelOrtho to Hold From Buy, Adjusts Price Target to $12.50 From $35	MT

ETFs positioned on QuidelOrtho Corporation

Name		Varia. Jan 1.	Weight	AuM
FIRST TRUST ALPHADEX U.S. HEALTH CARE SECTOR INDEX ETF - CAD HEDGED		-.--%	1.92%	2 M€

1 2

QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.

Employees

6,500

Sector

Advanced Medical Equipment & Technology

More about the company